Farmácia/Notícias da Indústria
Relatório OMS | Resistência antimicrobiana global e uso do sistema de vigilância.
11 Jun, 2021 | 10:35hComunicado de imprensa: Record response to WHO’s call for antimicrobial resistance surveillance reports in 2020 – World Health Organization
Comentário: WHO reveals new global antibiotic resistance data, more concerns – CIDRAP
Comentário no Twitter (fio – clique para saber mais)
WHO received over 3⃣ million reports for the Global #AntimicrobialResistance and Use Surveillance System (GLASS)
The more information we have the better placed the 🌏
is to tackle this increasingly serious health threat.👉 https://t.co/ccZCzdyZUc
pic.twitter.com/DMuLwVu4rC— World Health Organization (WHO) (@WHO) June 9, 2021
Estudo randomizado | Em pacientes com fibrilação atrial ou valvas cardíacas mecânicas, tratados com warfarina e submetidos à cirurgia, o tratamento pós-operatório com “ponte” (bridging treatment) de heparina de baixo peso molecular não evitou tromboembolismo maior.
11 Jun, 2021 | 10:33h
Comentário no Twitter
P-E-R-S-E-V-E-R-A-N-C-E = 15 yrs from start to BMJ publication. Bottom line: in pts with atrial fibrillation or mechanical heart valves who had warfarin interrupted for a procedure, we found no benefit of
postop LMWH bridging to prevent major
thromboembolism @canvector @CIHR_ICRH https://t.co/9z0XTQgsbA— Susan R Kahn (@SusanRKahn1) June 10, 2021
Estudo de coorte | O uso de medicações potencialmente inadequadas em adultos com doença crônica renal é comum e está associado a aumento do risco de hospitalização, mortalidade e quedas.
11 Jun, 2021 | 10:28hRisk of Potentially Inappropriate Medications in Adults With CKD: Findings From the Chronic Renal Insufficiency Cohort (CRIC) Study – American Journal of Kidney Diseases (link para o resumo – $ para o texto completo)
Comentário no Twitter
Risk of Potentially Inappropriate Medications in Adults With CKD: Findings From @CRICStudyhttps://t.co/1NgaqcJF5g@Rasheeda_HallMD @cjdiamantidis @sankarnava @finkjc @UMmedschool @DukeKidney #CKD #VisualAbstract pic.twitter.com/PLouT1SL9d
— AJKD (@AJKDonline) June 2, 2021
Série de casos | Imunoglobulina adjuvante para trombocitopenia trombótica induzida por vacina.
10 Jun, 2021 | 09:07hDiretriz 2021 do American College of Rheumatology para o tratamento da artrite reumatoide.
10 Jun, 2021 | 09:00hComentário: The 2021 Treatment Guidelines for Rheumatoid Arthritis – Rheumatology Network
[Preprint] Estudo RECOVERY mostra que aspirina não melhora a sobrevida de pacientes hospitalizados com COVID-19.
9 Jun, 2021 | 09:59hComunicado de imprensa: RECOVERY trial finds aspirin does not improve survival for patients hospitalised with COVID-19 – University of Oxford
Estudo original: Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial – medRxiv
Comentário no Twitter (fio – clique para saber mais)
RECOVERY Pre-print: Aspirin
14,892 patients randomised to aspirin vs. usual care
– no impact on all-cause mortality (17% vs. 17%)
– similar results in all pre-specified subgroupshttps://t.co/ay5Xg4GBVD pic.twitter.com/aNJ09RTTOa— Martin Landray (@MartinLandray) June 8, 2021
China vai vacinar crianças a partir de 3 anos de idade contra a COVID-19.
9 Jun, 2021 | 09:57hChina to offer COVID-19 vaccine to children as young as three – MedicalXpress
Ver também: Sinovac says its vaccine is safe for children as young as 3 – Associated Press
Aprovação do FDA para medicamento contra o Alzheimer gera controvérsia entre médicos.
9 Jun, 2021 | 09:49hComunicado de imprensa: FDA Grants Accelerated Approval for Alzheimer’s Drug – U.S. Food & Drug Administration
Comentários: ICER Issues Statement on the FDA’s Approval of Aducanumab for Alzheimer’s Disease – Institute for Clinical and Economic Review E Landmark Alzheimer’s Drug Approval Confounds Research Community – Nature E FDA approves Alzheimer’s drug from Biogen, against experts’ advice – NBC News E F.D.A. Approves Alzheimer’s Drug Despite Fierce Debate Over Whether It Works – The New York Times (alguns artigos gratuitos por mês) E Alzheimer’s drug approved despite doubts about effectiveness – Science (alguns artigos gratuitos por mês) E The FDA Has Approved A New Alzheimer’s Drug — Here’s Why That’s Controversial – NPR E Opinion: Bad medicine: aducanumab is a lackluster drug with a high price tag – STAT
Não foi observado aumento nos problemas de saúde em bebês cujas mães foram vacinadas contra a gripe durante a gestação.
9 Jun, 2021 | 09:47hNo health issues in babies whose moms got flu vaccine while pregnant – CIDRAP
Estudo original: Association of Maternal Influenza Vaccination During Pregnancy With Early Childhood Health Outcomes – JAMA (gratuito por tempo limitado)
Editorial: Realizing the Potential of Maternal Influenza Vaccination (gratuito por tempo limitado)
Comentário no Twitter
Thrilled to be part of this @JAMA_current study led by @deshaynef et al. showing that influenza immunization in pregnancy doesn't increase risk of asthma or infections in newborns https://t.co/0zscKLDm7L @ICESOntario @CANImmunize @DrJeffKwong @drkarinatop @Sprague_Ann
— Eric Benchimol (@ericbenchimol) June 8, 2021
Resumo | Recomendações da OMS para o tratamento da tuberculose resistente a medicamentos, atualização de 2020.
9 Jun, 2021 | 09:44hDiretriz original: WHO Consolidated Guidelines on Tuberculosis, Module 4: Treatment – Drug-Resistant Tuberculosis Treatment
Comentário no Twitter
🆕💥💥@ERSpublications
WHO guidelines on the treatment of drug-resistant TB contain the latest recommendations on shorter or longer all oral treatment regimens for patients with drug-resistant TB, including the medicines to be used& supportive measures https://t.co/qeeftVYdYN pic.twitter.com/4NKNNjz3Gh— Antibiotic Steward 🇵🇸💔Bassam Ghanem (@ABsteward) June 8, 2021